These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 2544812
1. Sodium channel-blocking properties of flecainide, a class IC antiarrhythmic drug, in guinea-pig papillary muscles. An open channel blocker or an inactivated channel blocker. Kojima M, Hamamoto T, Ban T. Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):441-7. PubMed ID: 2544812 [Abstract] [Full Text] [Related]
2. Nicorandil shortens action potential duration and antagonises the reduction of Vmax by lidocaine but not by disopyramide in guinea-pig papillary muscles. Kojima M, Ban T. Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):203-12. PubMed ID: 2966899 [Abstract] [Full Text] [Related]
3. Effects of AFD-21, a new class I antiarrhythmic agent, and AFD-19, its active metabolite, on the maximal rate of rise of action potentials in guinea pig papillary muscles: dependence on time, voltage, and action potential duration. Kojima M, Ban T. J Cardiovasc Pharmacol; 1989 Mar; 13(3):483-93. PubMed ID: 2471896 [Abstract] [Full Text] [Related]
5. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles. Pérez O, Valenzuela C, Delpón E, Tamargo J. Br J Pharmacol; 1994 Mar; 111(3):717-22. PubMed ID: 8019750 [Abstract] [Full Text] [Related]
6. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles. Pérez O, Valenzuela C, Delpón E, Tamargo J. Br J Pharmacol; 1997 Jan; 120(2):187-92. PubMed ID: 9117108 [Abstract] [Full Text] [Related]
7. Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration. Winslow E, Campbell JK. J Cardiovasc Pharmacol; 1991 Dec; 18(6):911-7. PubMed ID: 1725906 [Abstract] [Full Text] [Related]
8. Effect of flecainide on action potentials and alternating current-induced arrhythmias in mammalian myocardium. Borchard U, Boisten M. J Cardiovasc Pharmacol; 1982 Dec; 4(2):205-12. PubMed ID: 6175802 [Abstract] [Full Text] [Related]
9. Effects of combined use of class I antiarrhythmic agents on Vmax of guinea-pig ventricular muscles. Toyama J, Kawamura T, Kodama I. Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():801-4. PubMed ID: 1931757 [Abstract] [Full Text] [Related]
10. Electrophysiological effects of AFD-21 and AFD-19, new antiarrhythmic compounds on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts. Kodama I, Kamiya K, Kawamura T, Suzuki R, Toyama J. Br J Pharmacol; 1990 Dec; 101(4):803-8. PubMed ID: 2085705 [Abstract] [Full Text] [Related]
11. A model study of time- and voltage-dependent effects of class I antiarrhythmic drugs in guinea-pig papillary muscles as related to external potassium concentration. Hamamoto T, Kojima M, Matsuzaki M, Kusukawa R, Ban T. Arzneimittelforschung; 1994 Aug; 44(8):929-37. PubMed ID: 7945535 [Abstract] [Full Text] [Related]
12. Use- and concentration-dependent effects of flecainide in guinea pig right ventricular muscle. Rouet R, Ducouret P. J Cardiovasc Pharmacol; 1994 Aug; 24(2):177-83. PubMed ID: 7526048 [Abstract] [Full Text] [Related]
13. Effects of the enantiomers of flecainide on action potential characteristics in the guinea-pig papillary muscle. Vanhoutte F, Vereecke J, Carmeliet E, Verbeke N. Arch Int Pharmacodyn Ther; 1991 Aug; 310():102-15. PubMed ID: 1772323 [Abstract] [Full Text] [Related]
14. Electrophysiologic effects of TYB-3823, a new antiarrhythmic agent, on isolated guinea pig ventricular muscles. Kodama I, Morimoto M, Toyama J, Shibata S. J Cardiovasc Pharmacol; 1989 Apr; 13(4):616-23. PubMed ID: 2471000 [Abstract] [Full Text] [Related]
15. Electrophysiological effects of SD-3212, a new antiarrhythmic agent with vasodilator action, on guinea-pig ventricular cells. Kodama I, Suzuki R, Maruyama K, Toyama J. Br J Pharmacol; 1995 Jan; 114(2):503-9. PubMed ID: 7881749 [Abstract] [Full Text] [Related]
16. Voltage-dependent modification of Vmax recovery from use-dependent block by pirmenol in guinea pig papillary muscles: comparison with other class I drugs. Nakaya H, Shishido Y, Oyama Y, Kanno M. J Cardiovasc Pharmacol; 1992 Jan; 19(1):140-7. PubMed ID: 1375681 [Abstract] [Full Text] [Related]
17. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations. Pérez O, Gay P, Franqueza L, Carrón R, Valenzuela C, Delpón E, Tamargo J. Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178 [Abstract] [Full Text] [Related]
18. Effects of BW A256C, a novel class 1 antiarrhythmic agent, on maximum rate of depolarisation of cardiac action potentials in vitro: frequency, use, and voltage dependence. Donoghue S, Payne PN, Allan G. J Cardiovasc Pharmacol; 1987 Jan; 9(1):12-8. PubMed ID: 2434786 [Abstract] [Full Text] [Related]
19. Fast and slow blockade of sodium channels by flecainide in rabbit cardiac Purkinje fibres. Konzen G, Reichardt B, Hauswirth O. Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):565-76. PubMed ID: 2168022 [Abstract] [Full Text] [Related]
20. Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue. Wang Z, Fermini B, Nattel S. J Pharmacol Exp Ther; 1993 Nov; 267(2):575-81. PubMed ID: 8246130 [Abstract] [Full Text] [Related] Page: [Next] [New Search]